Myasthenia gravis (MG): non-steroid immunosuppression: indications
Evidence-based neurology checklist on myasthenia gravis (mg): non-steroid immunosuppression: indications: Indications for the sole use of non-steroid immunosuppressants When steroids are contraindicated When steroid side effects develop When there is pre-existing osteoporosis When there is…
Indications for the sole use of non-steroid immunosuppressants
- When steroids are contraindicated
- When steroid side effects develop
- When there is pre-existing osteoporosis
- When there is pre-existing ischaemic heart disease
- When there are significant bulbar or respiratory symptoms
Indications for combination therapy with steroids
References
- Skeie GO, Apostolski S, Evoli A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2010; 17:893-902.
- Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology 2016; 87:419-425.
Related checklists
- Myasthenia gravis (MG) treatment: pyridostigmine
- Myasthenia gravis (MG) treatment: steroids
- Myasthenia gravis (MG): non-steroid immunosuppression: agents
- Myasthenia gravis (MG): investigational treatments
- Thymectomy for non-thymoma myasthenia gravis (MG)
- Myasthenia gravis (MG): rehabilitation
- Myasthenia gravis (MG) and anaesthesia